chronicles.popvax.com

PopVax Goes Clinical - by Soham Sankaran

First participants safely dosed in Melbourne, Australia, on August 31, 2026, in the first-in-human trial of our broadly-protective COVID-19 vaccine candidate PVX-001.

If the page stays blank, open it in a new tab. Your Weird rating still works from the top bar.

Open source